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Abstract: A human papillomavirus (HPV) infection is globally one of the most common causes
of sexually transmitted infections of the mucous membranes (genital, anal and oral). Over the
last decade, an increasing number of young patients have been infected due to the changes in
sexual habits in the general population. The majority of the lesions are benign; however, substantial
scientific evidence has suggested a role for the HPV family in the carcinogenesis of squamous
cell carcinoma (SCC). It is proposed that dentists, in addition to ENT specialists, should apply
standardized management protocols in order to construct a well-defined pathway in terms of
diagnosis, which is based on a PCR diagnostic technique and the management of those lesions.
Keywords: human papillomavirus; HPV; oral mucosa; papilloma; squamous cell carcinoma; oral
cancer; OSCC; oropharynx cancer
It is the opinion of the authors of this paper that the growing clamour regarding
HPV-positive oropharyngeal cancer is a welcome opportunity for reconsidering and fo-
cusing on HPV oral diseases, which may affect areas of common interest for dentists and
ENT doctors, such as the oral mucosa. Of particular importance are those lesions which
are traditionally associated with Human Papillomavirus (HPV). These include: warts,
papillomas and condylomata (Figure 1). Departing from a lively interest in “HPV and
oropharynx cancer” [1,2], the psychological management of patients (young and old) af-
fected by such lesions can be considered a challenge. If, on the one hand, this condition
is a sign of the general awareness regarding the presence of sexually transmitted lesions
and the oncogenicity of viral lesions, on the other, it risks becoming a nightmare for many
teenagers and adults, who may be terrified by terrible malignant neoplasias.
It is common knowledge in the medical profession that genital HPV infection is
one of the most widespread sexually transmitted infections (STIs) throughout the global
population. In the United States it has been estimated that the prevalence of infection in
women aged between 19 and 54 years is approximately 40%, being markedly associated
with risk factors related to sexual behaviour [3]; in Europe, the prevalence of cervical
HPV infection with a high oncological risk is 3–15% in women aged 20 to 60 but it is
significantly higher (29–45%) in younger women (20–24 years) [4]. In light of the changes
in sexual habits in the general population in recent decades (for example, a reduction in
the age of the onset of sexual activity, an increase in the number of partners, oro–genital
sexual habits), the epidemiological characteristics of the HPV infection have changed as
a consequence. Both in the genital area and in the oropharyngeal area, there has been an
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increase in the number of younger patients being exposed to this infection [5], such that
many epidemiologists have now defined HPV infection as endemic.
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Figure 1. Oral lesions traditionally associated with LR-HPV: (a) wart on upper lips; (b) papilloma 
on ventral surface of tongue; (c) condyloma on soft palate; (d) condyloma on ventral surface of 
tongue. 
 
Figure 2. Proposed protocol for suspected HPV-related oral lesions. 
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This phenomenon would explain the increase in the frequency of HPV-related squa-
mous cell carcinoma (SCC) in the genital tract and oropharyngeal area. Specifically, it
has been found that the SCC of the tonsillar crypts and the base of tongue are signif-
icantly associated with the detection of high risk (HR) HPV (i.e., HR HPV 16) in ep-
ithelial cells (a risk of infection increased 13-fold in subjects with carcinoma, as com-
pared to healthy controls) [6]. These cancers have the same prognostic characteristics
as other oropharyngeal SCC, which should be treated in a preventive manner through
targeted awar ness campaigns around the world. For example, in order to dissemi-
nate preventive messages regarding HPV-related oral cancer among the general pop-
ulati n and patie ts, an i itiative has be n introdu d at the University Hospital of
Palermo (Italy) in the form of a flyer (http://giuseppinacampisi.it/wp-content/uploads/
flyers/Flyer_cancro_orale_e_hpv.pdf (accessed on 27 April 2021)), and YouTube video
(https://www.youtube.com/watch?v=-MaLE9JwGvk&t=14s (accessed on 27 April 2021)).
When scientifically defined, and according to the most recent ICD-3-0 site/histology
classification, i.e., excluding the base of the tongue, the frequency of HPV infection in the
oral squamous cell carcinoma (OSCC) in the oral cavity ranges between 3.3% to 13% [7–10].
It can therefore be considered appropriate to clarify various aspects relating to benign HPV
oral lesions in order to share their management through a standardized protocol.
What does HPV oral oncology have in common with warts, papillomas and condylomata
of the oral cavity and the oropharynx?
“Not much” might be the reply, notwithstanding bad press and hearsay. HPVs are typ-
ically distinguished by: (a) skin type, mainly infecting the hands and feet; and (b) mucosal
type, targeting: the mucosa of the oral cavity, the upper airways and digestive tract, the
anogenital district, the urethra and the conjunctiva. Based on the biological behaviour of
the lesions caused by the virus, there is a further classification of HPV into three groups:
HPV with a high oncogenic potential (high risk or HR-HPV), such as HPVs 16, 18, 45, 56,
59, 66, 67, 70, 73, 68, 82, associated with potentially and evidently malignant lesions (e.g.,
anogenital and head-neck SCC); HPV of intermediate cancerogenic potential, such as HPVs
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31, 33, 35, 39, 51, 52, 53, 58; and HPVs with low oncological potential (low risk or LR-HPV),
such as cutaneous HPVs 2, 4, 27 and the mucosal types 6, 11, 13, 32, 42, both of which are
prevalently associated with benign diseases (i.e., wart, condyloma, papilloma and focal
epithelial hyperplasia), as discussed in this paper. Referring to the latter (benign) lesions, it
would be opportune to engage with the patient, to reassure them about a clinical diagnosis
which is not associated with oral SCC or any malignant transformation. Thereafter the
possibility of an HPV infection and its possible genotype should be investigated.
Currently, the diagnosis of an HPV infection makes use of the techniques of nuclear
biology, the aim of which is to detect the DNA of the virus inside the cells by means of
marked genetic probes. The most sensitive and most appropriate biomolecular method
for identifying the HPV genome is the PCR (Polymerase Chain Reaction). Recently, an
SPF10-LiPA system has been introduced, which successively enhances the PCR method and
genotype identification. It has been found to display elevated sensitivity and specificity,
ease of use and the possibility of identifying multiple and persistent infections [11]. Many
in the field consider that PCR techniques are preferrable to indirect techniques of viral
activity as the latter are responsible for a variable rate of false negatives. Regarding a
definitively safe and standardized HPV detection technique, a standard diagnostic protocol
relating to the oral cavity has not yet been established in terms of: (a) the sample type
under biomolecular investigation (e.g., histological sample vs. exfoliated cells); (b) the
cytological sampling method (e.g., brush vs. oral rinse); (c) a procedure for the preservation
of the histological sampling (e.g., frozen fresh vs. fixed in formalin and paraffin); and (d) a
specific biomolecular technique to be used. The direct consequences of these weaknesses
are evident. Irrespective of such weaknesses, a protocol can be used thus: in the presence of
a single/multiple exophytic lesion(s) with a slow-growing, warty surface in the absence of
local traumatic factors (e.g., mechanical, physical, chemical), the HPV test can be performed
on cytological sampling, which must be performed prior to the excision of the oral lesion,
or directly onto a paraffin section of the histological sample (according to the criteria of a
given microbiological laboratory of referral) (Figure 2). Thereafter, an excisional biopsy of
the lesion and confirmation of the histopathological diagnosis will be conducted. Follow-up
at 6 and 12 months is advisable in order to ascertain any recurrence [12]. Where an HPV
test is positive, follow-up should reoccur at 6–12 months and, where possible, after another
12-month period until the test is negative [12]. Many authors believe that it is indispensable
to share this latter clinical protocol with dentists and ENT doctors in order to construct a
not dissimilar pathway of the diagnosis and management of these benign lesions, which
are typically associated with an LR-HPV infection.
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